MedPharm Former CSO Champions Company Innovation
January 25, 2021
MedPharm appointments Dr Jon Lenn as Chief Scientific Officer
MedPharm Ltd, the world’s leading contract service provider of contract topical and transdermal product design and formulation development services, has launched its Scientific Advisory Committee, headed by company founder and Board member, Professor Marc Brown. Marc Brown has served as MedPharm’s Chief Scientific Officer for over 20 years and will be stepping down from his CSO role to chair the newly formed committee.
Comprised of world-renowned international experts, the Scientific Advisory Committee will ensure that MedPharm continues to provide its clients with industry leading scientific services and access to beneficial strategic alliances. In addition to his role as committee chair, Marc will continue to provide technical as well as client support when required and remains a Board Director.
Dr Jon Lenn will take over the role of CSO, with responsibility for MedPharm’s global scientific operations. Jon is well established as an authority in the development and optimization of topical products and has played a critical role in MedPharm’s growth as well as the development and success of the Durham, NC site. More recently as Chief Technology Officer, Jon has guided the Innovation Team in the development of cutting-edge biological models and performance testing tools and supported client’s needs.
“I would like to thank Marc for what he has accomplished as MedPharm’s scientific leader, and I am pleased that despite wanting to move away from day-to-day operations, he has elected to remain engaged with MedPharm’s platform. With his support as chair of the Scientific Advisory Committee, we will continue our pioneering standard and remain the world leader in the topical and transdermal CDMO field, commented Eugene Ciolfi, President & CEO. “Jon is the perfect individual to step into the CSO role. His unparalleled experience across MedPharm and the Pharma industry will ensure our continued excellence in the science undertaken at MedPharm.”
These changes demonstrate MedPharm’s commitment to a global vision to expand services and remain at the forefront of the CDMO topical and transdermal product development industry.
MedPharm is the world’s leading contract provider of topical and transdermal formulation development and manufacturing services. Our experts specialize in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through cost-effective and industry-leading performance testing models. Well-established as the global leader in dermal and transdermal product development, MedPharm also offers innovative solutions for airway, ophthalmic, otic, ungual, and other topical preparations. With locations in both the US and the UK, MedPharm is the CDMO of choice for developers around the globe.